1
TITLE: Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2)  Full Text
AUTHORS: Kennelly, Michael; Cruz, Francisco; Herschorn, Sender; Abrams, Paul; Onem, Kadir; Solomonov, Viktor Kibanov; Figueroa Coz, Elena del Rosario; Manu Marin, Andrei; Giannantoni, Antonella; Thompson, Catherine; Vilain, Claire; Volteau, Magali; Denys, Pierre;
PUBLISHED: 2022, SOURCE: EUROPEAN UROLOGY, VOLUME: 82, ISSUE: 2
INDEXED IN: Scopus WOS
2
TITLE: Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo  Full Text
AUTHORS: Chapple, CR; Cruz, F ; Cardozo, L; Staskin, D; Herschorn, S; Choudhury, N; Stoelzel, M; Heesakkers, J; Siddiqui, E;
PUBLISHED: 2020, SOURCE: EUROPEAN UROLOGY, VOLUME: 77, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 37
3
TITLE: The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction  Full Text
AUTHORS: Carlos D'Ancona; Bernard Haylen; Matthias Oelke; Luis Abranches Monteiro; Edwin Arnold; Howard Goldman; Rizwan Humid; Yukio Homma; Tom Marcelissen; Kevin Rademakers; Alexis Schizas; Ajay Singla; Irela Soto; Vincent Tse; Stefan de Wachter; Sender Herschorn;
PUBLISHED: 2019, SOURCE: NEUROUROLOGY AND URODYNAMICS, VOLUME: 38, ISSUE: 2
INDEXED IN: Scopus WOS
4
TITLE: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology (vol 30, pg 819, 2013)  Full Text
AUTHORS: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLISHED: 2014, SOURCE: ADVANCES IN THERAPY, VOLUME: 31, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
5
TITLE: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology  Full Text
AUTHORS: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLISHED: 2013, SOURCE: ADVANCES IN THERAPY, VOLUME: 30, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 69
6
TITLE: Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial  Full Text
AUTHORS: Cruz, F ; Herschorn, S; Aliotta, P; Brin, M; Thompson, C; Lam, W; Daniell, G; Heesakkers, J; Haag Molkenteller, C;
PUBLISHED: 2011, SOURCE: EUROPEAN UROLOGY, VOLUME: 60, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 364
7
TITLE: EFFICACY AND SAFETY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY  Full Text
AUTHORS: Cruz, F ; Herschorn, S; Heesakkers, J; Aliotta, P; Thompson, C; Lam, W; Daniell, G; Haag Molkenteller, C;
PUBLISHED: 2011, SOURCE: EUROPEAN UROLOGY SUPPLEMENTS, VOLUME: 10, ISSUE: 2
INDEXED IN: WOS